New York PDAB
Medicaid Drug Utilization Review Board (DURB)
Authorized to evaluate high-cost drugs exceeding spending thresholds and negotiate supplemental manufacturer rebates.
Department of Financial Services (DFS)
Investigates prescription pricing trends and is advised by a dedicated Drug Accountability Board.
Legislative Efforts
Pushes have included the Affordable Drug Manufacturing Act to target high-cost generic drugs and shortages, alongside measures addressing insulin affordability.
